X
Power Law company profile
Xencor
Biotech & Life Sciences · Monrovia, United States · Founded 1997 · IPO 2013 Thoroughbred
Valuation
$524M
Market cap · May/2026
Revenue
$126M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Investors
5 investors on Xencor's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Series B+
5 investors entered at this stage
Global footprint
Where Xencor has talent and traffic
Workforce by country
2
countries with
team presence
team presence
🇺🇸 United States99.5%
🇦🇷 Argentina0.5%
Web traffic by country
9.5K
monthly visits
across markets
across markets
🇺🇸 United States64.2%
🇬🇧 United Kingdom21.1%
🇮🇳 India14.7%
Market sentiment
What the market is saying about Xencor
An AI-synthesized read of the highest-engagement posts about Xencor on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xencor on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.